术前N末端B型利钠肽原能否预测髋部骨折术后心脏并发症
研究纳入328例无肾功能障碍的髋部骨折手术患者,术前检测NT-proBNP,以术后14天内心脏并发症为主要终点。术前NT-proBNP中位水平在发生并发症者中更高(1090 pg/mL vs 283 pg/mL),ROC曲线确定的截断值为600 pg/mL,校正混杂因素后NT-proBNP>600 pg/mL与心脏并发症风险升高相关(OR 13,95%CI 4-38)。
要点
- 髋部骨折术后7%(24/328)发生心脏并发症。
- 并发症组术前NT-proBNP中位1090 pg/mL,无并发症组283 pg/mL。
- NT-proBNP>600 pg/mL者心脏并发症风险约为对照的13倍(OR 13,95%CI 4-38)。
核心结论
- 无肾功能障碍的髋部骨折患者,术前NT-proBNP>600 pg/mL与术后心脏并发症独立相关。
- 术前NT-proBNP检测可提供额外信息,有助于预测髋部骨折术后早期心脏并发症。
- 作者认为未来研究可能开发包含NT-proBNP截断值的简易预测指数。
研究设计与样本
- 2011年1月至2014年12月共实施450例髋部骨折手术,排除肾功能障碍和实验室检查不充分者后,最终研究人群为328例,平均年龄83岁,80%为女性。
- 术前检测NT-proBNP水平,主要终点为基于病历审查的术后14天内心脏并发症。
- 采用多变量logistic回归分析(控制年龄、性别、体重和肾功能等混杂因素)及ROC曲线分析评估NT-proBNP的预测价值。
- 证据等级为III级,诊断性研究。
主要发现
- 术后心脏并发症发生于7%的患者(24/328)。
- 术前NT-proBNP中位水平在并发症组为1090 pg/mL(四分位距614-3191 pg/mL),无并发症组为283 pg/mL(四分位距137-507 pg/mL),p<0.001。
- ROC曲线确定的NT-proBNP截断值为600 pg/mL,敏感度79%、特异度81%、阳性预测值25%、阴性预测值98%,曲线下面积0.87(95%CI 0.80-0.94;p<0.001)。
- 校正潜在混杂因素后,术前NT-proBNP>600 pg/mL者较NT-proBNP<600 pg/mL者心脏并发症风险升高(OR 13;95%CI 4-38;p<0.001)。
关键数值与推荐
- NT-proBNP截断值600 pg/mL由ROC曲线分析确定。
- NT-proBNP>600 pg/mL预测心脏并发症的敏感度79%、特异度81%、阳性预测值25%、阴性预测值98%。
- 曲线下面积0.87(95%CI 0.80-0.94;p<0.001)。
- 校正混杂因素后OR 13(95%CI 4-38;p<0.001)。
临床怎么用
- 作者认为术前NT-proBNP检测可提供额外信息,对预测髋部骨折术后早期心脏并发症有临床用处。
- 作者认为未来研究可能开发包含NT-proBNP截断值的简易预测指数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elderly patients with hip fracture are at risk for cardiac complications. N-terminal pro-brain type natriuretic peptide (NT-proBNP) has been shown to predict cardiac complications in surgical patients; however, to our knowledge, only two studies have evaluated the utility of this test in patients with hip fracture. We believe it is important to assess a more accurate cutoff value of NT-proBNP with exclusion of patients with renal failure. QUESTIONS/PURPOSES: To assess the association between preoperative NT-proBNP and cardiac complications after hip fracture surgery. METHODS: We performed 450 surgical procedures in patients with hip fractures between January 2011 and December 2014. Exclusion criteria were renal dysfunction and inadequate laboratory tests. The final study population consisted of 328 patients (mean age, 83 years; 80% women). Preoperatively, measurement of NT-proBNP level was performed. The primary endpoint was the occurrence of cardiac complications within 14 days after surgery based on a chart review. The predictive value of NT-proBNP was assessed using multivariate logistic regression analysis, controlling for relevant confounding variables such as age, gender, body weight, and renal function; we also performed receiver operating characteristic (ROC) curve analysis. Postoperative cardiac complications were encountered in 7% of patients (24 of 328). RESULTS: The median preoperative NT-proBNP level was higher in patients with complications than in those without (1090 [interquartile range, 614-3191 pg/mL] vs 283 pg/mL [interquartile range, 137-507 pg/mL], p < 0.001). The cutoff level of NT-proBNP determined by ROC curve analysis was 600 pg/mL, with a sensitivity, specificity, positive predictive value, and negative predictive value of 79%, 81%, 25%, and 98%, respectively, and the area under the ROC curve was 0.87 (95% CI, 0.80-0.94; p < 0.001). After controlling for potentially relevant confounding variables, we found a preoperative NT-proBNP greater than 600 pg/mL was associated with an increased risk of cardiac complications (odds ratio, 13; 95% CI, 4-38; p < 0.001) compared with those with NT-proBNP less than 600 pg/mL. CONCLUSIONS: Preoperative NT-proBNP greater than 600 pg/mL is independently associated with postoperative cardiac complications in patients with hip fracture without renal dysfunction. NT-proBNP measurement provides additional information and is clinically useful for predicting cardiac complications during the early phase after hip fracture surgery. Future studies might develop a simple index for prediction of postoperative cardiac complication including cutoff values of NT-proBNP. LEVEL OF EVIDENCE: Level III, diagnostic study.
引用
- Ushirozako H, Ohishi T, Fujita T, et al. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery? Clin Orthop Relat Res. 2017. PMID: 28101755. doi:10.1007/s11999-017-5245-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。